聯想創投梁穎:人機融合實現後 希望看到人類增強而不是替代
《新浪科技》報道,聯想集團(00992.HK)旗下聯想創投董事總經理梁穎表示,腦機接口一個很大的應用領域是在醫療,醫療領域除了神經相關的疾病,不管是老年癡呆及抑鬱等,是腦機接口很好的應用領域。另外,跟康復和神經修復相關的也是看好的方向。
她提及,人機融合實現後的一些挑戰。如馬斯克的終極目標是碳基跟矽基融合,有一天一定要把人的意識下載,到那一天包括安全隱私問題的社會倫理問題就非常挑戰。她預期未來終局可能真的是矽基跟碳基去融合,希望看到的是人類的增強,不是人類的替代。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.